-
Mashup Score: 1HFA 24: Differential Effects of Inter-Atrial Shunt Treatment in HF Patients with Reduced Vs Preserved Ejection Fraction: RELIEVE-HF - 22 hour(s) ago
HFA 24 – We are joined onsite by Dr Michael Zile (Medical University of South Carolina, US) to discuss the outcomes of the RELIEVE-HF trial.RELIEVE-HF is designed to evaluate the safety
Source: www.cfrjournal.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 11HFA 24: FINE-HEART: Design & Baseline Characteristics - 1 day(s) ago
HFA 24 – We are joined by Dr Muthiah Vaduganathan (Brigham and Women’s Hospital, US) to discuss the design and baseline characteristics of the FINE-HEART(Bayer) integrated pooled analysis
Source: www.cfrjournal.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 9
HFA 2024 — Dr Tauben Averbuch and Dr Harriette Van Spall (McMaster University, Hamilton, CA) discuss the findings from the PACT-HF trial. In this analysis of PACT-HF, investigators looked at
Source: www.cfrjournal.comCategories: General Medicine News, Partners & KOLsTweet-
🎙️NEW #HeartFailure2024 #LBCT Discussion 💫Dr @hvanspall & Dr @TaubenA discuss the findings from the PACT-HF trial. 📽️Watch here👉 https://t.co/OZiw8ISm4W 📊Clinical outcomes and overall costs following hospitalisation for #HF were similar between male and female patients at… https://t.co/WWvpOJIJph https://t.co/qicYukgHWw
-
-
Mashup Score: 8HFA 24 Late-Breaker Discussion: Insights from the STEP-HFpEF - 3 day(s) ago
HFA 2024 — Late-breaker host, Dr Harriette Van Spall sat down with Dr Mikhail Kosiborod to discuss insights from the STEP-HFpEF programme.STEP HFpEF aimed to test the hypothesis that treatment
Source: www.cfrjournal.comCategories: General Medicine News, Partners & KOLsTweet-
🎙️NEW #HeartFailure2024 #LBCT Discussion 💫Dr @hvanspall & Dr @MkosiborodMD discuss findings from the STEP-HFpEF study. 📽️Watch here👉 https://t.co/SE4qxWqXzg 📊All pts benefited from #semaglutide, regardless of NTproBNP 📊Pts at higher NTproBNP levels had greater improvement… https://t.co/8Ky6YhGw9I https://t.co/VWaihHsIJB
-
-
Mashup Score: 14HFA 24 Late-Breaker Discussion: The TITRATE-HF Study - 3 day(s) ago
HFA 24 – Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) joined onsite by Dr Jasper Brugts (Erasmus University Medical Centre, NL) to discuss the first results from the
Source: www.cfrjournal.comCategories: General Medicine News, Partners & KOLsTweet-
🎙️NEW #HeartFailure2024 #LBCT Discussion 💫Dr @hvanspall & Dr Jasper Brugts discuss findings from the TITRATE-HF study, which assessed drug sequencing strategies for #GDMT initiation in pts with de novo, worsening and chronic HF. 📽️Watch here👉 https://t.co/rEDh8OFoUk 📊#SGLT2i… https://t.co/4Estp54KXl https://t.co/M2kLfDySS2
-
-
Mashup Score: 5HFA 24: Timing of Cardio-Kidney Protection with SGLT2i - 4 day(s) ago
HFA 24 – We are joined by Dr Muthiah Vaduganathan (Brigham and Women’s Hospital, US) to discuss the findings from a study of four large-scale placebo controlled-trials investigating the timing
Source: www.cfrjournal.comCategories: General Medicine News, Partners & KOLsTweet-
🎙️NEW #HeartFailure2024 #LBCT Interview 💫Dr @mvaduganathan joins us to discuss findings from the study of four trials investigating the timing of cardio-kidney protection with SGLT2 inhibitors. 📽️Watch here👉 https://t.co/GfJgbgAEXo 📊#HF events were strikingly modifiable and… https://t.co/WV4djDJlis https://t.co/IYPCE9SCJ2
-
-
Mashup Score: 0
HFA 24 – We are joined onsite by Dr Michael Kiernan (Tufts University School of Medicine, US) to discuss the findings from the PROACTIVE-HF 2 Trial.PROACTIVE-HF 2 is a prospective,
Source: www.cfrjournal.comCategories: General Medicine News, Partners & KOLsTweet-
🎙️NEW #HeartFailure2024 #LBCT Interview 💫Dr Michael Kiernan discusses findings from the PROACTIVE-HF 2 trial. 📽️Watch here👉 https://t.co/UwmNMc8n67 📊The Cordella system was: ✅ Safe with freedom from device implant complications and sensor failure (<1%) ✅ Effective in terms… https://t.co/oqG3pPbtrl https://t.co/DLz5AlEvDY
-
-
Mashup Score: 0HFA 24: Aspirin Avoidance after Implantation of a Fully Magnetically Levitated LVAD: ARIES HM3 - 4 day(s) ago
HFA 24 – Dr Finn Gustafsson (Rigshospitalet, DK) joined us onsite at the Heart Failure Association Congress to discuss the findings from a subanalysis of the ARIES HeartMate 3
Source: www.cfrjournal.comCategories: General Medicine News, Partners & KOLsTweet-
🎙️NEW #HeartFailure2024 #LBCT Interview 💫Dr @FinnGustafsson discusses the findings from a sub-analysis of the ARIES HeartMate 3 study, which looked at omission of aspirin from antithrombotic regimen for pts with LVAD HeartMate 3. 📽️Watch here👉 https://t.co/UGwcqFqKyx 📊No… https://t.co/Igiy2DvEpo https://t.co/NKXy6QVMbE
-
-
Mashup Score: 3HFA 24: Treatment Benefit Consistency of Remote Hemodynamic Monitoring in CHF: MONITOR-HF Subgroup Analysis - 5 day(s) ago
HFA 24 – We are joined by Dr Jasper J Brugts (Erasmus University Medical Centre, NL) to discuss the findings of a predefined subgroup analysis of the MONITOR-HF study (NTR7672).MONITOR-HF was
Source: www.cfrjournal.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 2The Therapy and Management of Heart Failure with Preserved Ejection Fraction: New Insights on Treatment - 1 month(s) ago
Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome characterised by the presence of diastolic dysfunction and elevated left ventricular filling pressure, in the setting
Source: www.cfrjournal.comCategories: General Medicine News, Partners & KOLsTweet
🎙️NEW #HeartFailure2024 #LBCT Interview 💫Prof Michael Zile joins us to discuss the outcomes of the RELIEVE-HF trial. 📽️Watch here👉 https://t.co/IQvTGoAXUe 📊In #HFrEF, interatrial shunt treatment was tolerated without increased right ventricular preload or afterload. 📊In… https://t.co/ze1zrNqhk1 https://t.co/imlSgZ4lAD